Comparison of breast tissue markers for tumor localization in breast cancer patients undergoing neoadjuvant chemotherapy.

Ultrasonography · 2019 · PMC6769188 · PMID 31378014

Europe PMC DOI

hedged sentence

0.1830

closest p · 3.7× alpha

0.1830

boldest claim

The sentences

did not reach statistical significanceP=0.183not close (p > 0.1)

The proportion of US-guided localizations was higher when using Cormark markers (75.0%, 6 of 8) than when using UltraClip markers (38.5%, 5 of 13) when no residual lesion was noted on US after NAC, but this trend did not reach statistical significance (P=0.183) ( Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.